小摩：将葛兰素史克目标价上调至1500便士

Core Viewpoint - Morgan Stanley raised the target price for GlaxoSmithKline from 1400 pence to 1500 pence [1] Company Summary - The adjustment in target price reflects a positive outlook on GlaxoSmithKline's performance and potential growth in the market [1]